Related Experiment Video
Updated: Oct 16, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Methylation Modification, Alternative Splicing, and Noncoding RNA Play a Role in Cancer Metastasis through Epigenetic
Bin Yu1, Xin Yu2, Jianping Xiong2
1Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China.
Abstract:
Metastasis is the leading cause of cancer-related deaths. Understanding the pathogenesis of metastasis at the molecular levels is of great significance for cancer research. However, the molecular diagnosis or treatment of cancer metastasis is limited. Accumulating and growing evidence shows that epigenetic changes are present in all human cancers, and epigenetic regulation is an indispensable factor to promote tumor metastasis. With the deepening of research and the advancement of technology, the function and mechanism of epigenetic regulation, including DNA methylation, histone/RNA modification, and precursor messenger RNA alternative splicing and noncoding RNAs, has become more increasingly clear. At present, the application of epigenetic therapies in tumor treatment is becoming a feasible therapeutic route. In this review, we looked for the key molecules in epigenetic regulation and discuss their relative regulating mechanisms in cancer metastasis. Furthermore, we highlight promising therapeutic strategies, including monitoring serum DNA for diagnostic purposes and early phase clinical trial therapies that target DNA and histone methylation. This may also be beneficial in finding new targets for further prognosis and diagnosis of cancer metastasis.
Insights
Epigenetic alterations drive cancer metastasis, impacting patient survival. Targeting these epigenetic mechanisms offers promising new diagnostic and therapeutic strategies for cancer.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Cancer metastasis is the primary cause of cancer-related mortality.
- Current molecular diagnosis and treatment for metastasis remain limited.
- Epigenetic modifications are prevalent in cancers and crucial for tumor metastasis.
Purpose of the Study:
- To review key epigenetic regulatory molecules and their mechanisms in cancer metastasis.
- To highlight emerging epigenetic therapies and diagnostic strategies for cancer metastasis.
Main Methods:
- Literature review focusing on epigenetic regulation in cancer metastasis.
- Analysis of molecular mechanisms including DNA methylation, histone/RNA modification, alternative splicing, and noncoding RNAs.
- Examination of current and emerging therapeutic strategies targeting epigenetic modifications.
Main Results:
- Epigenetic regulation, encompassing DNA methylation, histone/RNA modifications, and noncoding RNAs, plays a critical role in promoting cancer metastasis.
- Emerging epigenetic therapies targeting these modifications show promise for tumor treatment.
- Monitoring serum DNA and targeting DNA/histone methylation are identified as potential diagnostic and therapeutic avenues.
Conclusions:
- Epigenetic mechanisms are fundamental to cancer metastasis and represent a viable therapeutic target.
- Novel strategies like serum DNA monitoring and targeted epigenetic therapies offer new hope for improved cancer prognosis and diagnosis.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
MicroRNAs
RNA Splicing
What is Gene Expression?

